These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12487926)

  • 41. Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF).
    Shi YP; Ferrara N
    Biochem Biophys Res Commun; 1999 Jan; 254(2):480-3. PubMed ID: 9918864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth.
    Filleur S; Courtin A; Ait-Si-Ali S; Guglielmi J; Merle C; Harel-Bellan A; Clézardin P; Cabon F
    Cancer Res; 2003 Jul; 63(14):3919-22. PubMed ID: 12873985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells.
    Benckert C; Jonas S; Cramer T; Von Marschall Z; Schäfer G; Peters M; Wagner K; Radke C; Wiedenmann B; Neuhaus P; Höcker M; Rosewicz S
    Cancer Res; 2003 Mar; 63(5):1083-92. PubMed ID: 12615726
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unique properties of 189 amino acid isoform of vascular endothelial growth factor in tumorigenesis.
    Tomii Y; Yamazaki H; Sawa N; Ohnishi Y; Kamochi J; Tokunaga T; Osamura Y; Sadahiro S; Kijima H; Abe Y; Ueyama Y; Tamaoki N; Nakamura M
    Int J Oncol; 2002 Dec; 21(6):1251-7. PubMed ID: 12429975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Gabrilovich DI; Ishida T; Nadaf S; Ohm JE; Carbone DP
    Clin Cancer Res; 1999 Oct; 5(10):2963-70. PubMed ID: 10537366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relationship of hypoxia-inducible factor-1alpha expression and vascular endothelial growth factor in SKOV-3 ovarian cancer model].
    Jiang HY; Feng YJ
    Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):767-70. PubMed ID: 15634505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells.
    Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I
    Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor and antimetastatic activity of ribozymes targeting the messenger RNA of vascular endothelial growth factor receptors.
    Pavco PA; Bouhana KS; Gallegos AM; Agrawal A; Blanchard KS; Grimm SL; Jensen KL; Andrews LE; Wincott FE; Pitot PA; Tressler RJ; Cushman C; Reynolds MA; Parry TJ
    Clin Cancer Res; 2000 May; 6(5):2094-103. PubMed ID: 10815937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of the VEGF-system in the endometrium during steroid-replacement and early pregnancy of pigs.
    Welter H; Wollenhaupt K; Tiemann U; Einspanier R
    Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):33-40. PubMed ID: 12605348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Mechanisms and role of lymphangiogenesis in cancer metastasis].
    Dupuy E; Tobelem G
    Bull Cancer; 2003 Jul; 90(7):595-9. PubMed ID: 12957800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor.
    Gossmann A; Helbich TH; Mesiano S; Shames DM; Wendland MF; Roberts TP; Ferrara N; Jaffe RB; Brasch RC
    Am J Obstet Gynecol; 2000 Oct; 183(4):956-63. PubMed ID: 11035346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
    Qi SY
    Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The inhibitory action of the antisense oligodeoxynucleotide to the expression of vascular endothelial growth factor by radiotherapy in a prostate cancer cell line].
    Meng DY; Xue WC; Hu XF; Wang YN; Luo J
    Zhonghua Nan Ke Xue; 2002; 8(2):95-7. PubMed ID: 12479018
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular endothelial growth factor isoform expression as a determinant of blood vessel patterning in human melanoma xenografts.
    Yu JL; Rak JW; Klement G; Kerbel RS
    Cancer Res; 2002 Mar; 62(6):1838-46. PubMed ID: 11912163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
    Bae DG; Kim TD; Li G; Yoon WH; Chae CB
    Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.